Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Intestinal knockout of Nedd4 enhances growth of Apcmin tumors

    Nedd4 (Nedd4-1) is an E3 ubiquitin ligase that belongs to the HECT family and comprises a C2-WW(n)-HECT domain architecture. Although it has been reported to regulate growth factor receptors and cellular signa...

    C Lu, C Thoeni, A Connor, H Kawabe, S Gallinger, D Rotin in Oncogene (2016)

  2. Article

    Open Access

    Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole

    Hypoxia is thought to be an adverse feature of pancreatic cancer, but direct measurement in patients is technically challenging. To address this, we characterised the intra/interpatient heterogeneity of hypoxi...

    N C Dhani, S Serra, M Pintilie, J Schwock, J Xu, S Gallinger in British Journal of Cancer (2015)

  3. Article

    Open Access

    BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts

    Germline mutations of the BRCA tumour suppressors have been associated with increased risk of pancreatic cancer. Clinical evidence suggests that these patients may be more sensitive to treatment with cisplatin...

    I Lohse, A Borgida, P Cao, M Cheung, M Pintilie, T Bianco in British Journal of Cancer (2015)

  4. No Access

    Article

    A genome-wide association study of anorexia nervosa

    Anorexia nervosa (AN) is a complex and heritable eating disorder characterized by dangerously low body weight. Neither candidate gene studies nor an initial genome-wide association study (GWAS) have yielded si...

    V Boraska, C S Franklin, J A B Floyd, L M Thornton, L M Huckins in Molecular Psychiatry (2014)

  5. Article

    Open Access

    Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers

    The BRCA1/2 proteins are involved in regulation of cellular proliferation by DNA damage repair via homologous recombination. Therefore, BRCA1/2 mutation carriers with pancreatic cancer may have distinct biologic ...

    T Golan, Z S Kanji, R Epelbaum, N Devaud, E Dagan, S Holter in British Journal of Cancer (2014)

  6. Article

    Open Access

    Characterisation of Familial Colorectal Cancer Type X, Lynch syndrome, and non-familial colorectal cancer

    Familial Colorectal Cancer Type X (FCCTX) is defined as individuals with colorectal cancer (CRC) who families meet Amsterdam Criteria-1 (AC1), but whose tumours are DNA-mismatch-repair-proficient, unlike Lynch...

    S Shiovitz, W K Copeland, M N Passarelli, A N Burnett-Hartman in British Journal of Cancer (2014)

  7. No Access

    Article

    Chemotherapy of MMR-deficient colorectal cancer

    Colorectal cancer (CRC) continues to rank as the third most common cancer in Western society and the second leading cause of cancer death in North America. There are at least three distinct, and relatively dis...

    N. Devaud, S. Gallinger in Familial Cancer (2013)

  8. Article

    Open Access

    Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers

    JG Dowty, AK Win, D Buchanan, RJ Macinnis in Hereditary Cancer in Clinical Practice (2012)

  9. Article

    Open Access

    Metachronous colon cancer risk following surgery for first primary rectal cancer in Lynch syndrome

    S Parry, AK Win, B Parry, M Kalady, FA Macrae in Hereditary Cancer in Clinical Practice (2012)

  10. No Access

    Article

    Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis

    The liver is a major site of metastasis for human malignancies, yet the factors that regulate tumor cell survival and growth in this organ remain elusive. Previously, we reported that M-27IGF−IR murine lung carci...

    J V Burnier, N Wang, R P Michel, M Hassanain, S Li, Y Lu, P Metrakos, E Antecka in Oncogene (2011)

  11. Article

    Open Access

    Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients

    In colorectal cancer (CRC), tumour microsatellite instability (MSI) status and CpG island methylator phenotype (CIMP) status are indicators of patient outcome, but the molecular events that give rise to these ...

    J B Rawson, M Mrkonjic, D Daftary, E Dicks, D D Buchanan in British Journal of Cancer (2011)

  12. Article

    Open Access

    Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes

    Carriers of germline mutations in DNA mismatch repair (MMR) genes have a high risk of colorectal cancer (CRC), but the modifiers of this risk are not well established. We estimated an association between body ...

    A K Win, J G Dowty, D R English, P T Campbell, J P Young in British Journal of Cancer (2011)

  13. Article

    Open Access

    A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants

    Defective DNA repair has a causal role in hereditary colorectal cancer (CRC). Defects in the base excision repair gene MUTYH are responsible for MUTYH-associated polyposis and CRC predisposition as an autosomal r...

    E Theodoratou, H Campbell, A Tenesa, R Houlston, E Webb in British Journal of Cancer (2010)

  14. Article

    Open Access

    Erratum: COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

    Correction to: British Journal of Cancer 102, 447–454. doi: 10.1038/sj.bjc.6605338 Upon online publication of the above article on 17 November last year (and now this issue), it was noted that two of the autho...

    I P M Tomlinson, M Dunlop, H Campbell, B Zanke, S Gallinger in British Journal of Cancer (2010)

  15. Article

    Open Access

    COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

    It is now recognised that a part of the inherited risk of colorectal cancer (CRC) can be explained by the co-inheritance of low-penetrance genetic variants. The accumulated experience to date in identifying th...

    I P M Tomlinson, M Dunlop, H Campbell, B Zanke, S Gallinger in British Journal of Cancer (2010)

  16. Article

    Open Access

    Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer

    ApoE single nucleotide polymorphisms (SNPs) Cys112Arg (Epsilon-4), and Arg158Cys (Epsilon-2) have been implicated in cardiovascular and Alzheimer's disease, but their role in colorectal cancer (CRC) has not be...

    M Mrkonjic, E Chappell, V V Pethe, M Manno, D Daftary in British Journal of Cancer (2009)

  17. No Access

    Article

    Percutaneous Ethanol Injection of Unresectable Medium-to-Large-Sized Hepatomas Using a Multipronged Needle: Efficacy and Safety

    Fine needles with an end hole or multiple side holes have traditionally been used for percutaneous ethanol injection (PEI) of hepatomas. This study retrospectively evaluates the safety and efficacy of PEI of u...

    C.S. Ho, J.R. Kachura, S. Gallinger in CardioVascular and Interventional Radiology (2007)

  18. No Access

    Article

    Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies

    Newfoundland has the highest rate of colorectal cancer (CRC) of any Canadian province. In order to investigate the factors, especially genetic components, responsible for CRC we established the Newfoundland Co...

    R. C. Green, J. S. Green, S. K. Buehler, J. D. Robb, D. Daftary in Familial Cancer (2007)

  19. No Access

    Article

    Survival following repeat hepatectomy for metastatic colorectal cancer

    A. C. Wel, I. D. McGilvray, D. Grant, M. Cattral, B. Taylor in Annals of Surgical Oncology (2004)

  20. No Access

    Article

    Predictive value of 3D computed tomography in assessing hepatic volumes prior to resection

    M. Molinari, C. Vollmer, I. McGilvray, S. Gallinger in Annals of Surgical Oncology (2004)

previous disabled Page of 2